⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVO News
Novo-Nordisk A/S
The Brain & Behavior Research Foundation Presents: Neural Circuits Controlling Food-Seeking
globenewswire.com
NVO
Genomics Launches the Mystra AI Platform, Adopted by Industry Giants and Up-and-Coming Biotechs
prnewswire.com
AMZN
NVO
Parker Waichman LLP Files Lawsuit on behalf of Pennsylvania Resident Alleging Development of Irreversible Eye Condition, NAION, after taking Wegovy
prnewswire.com
NVO
Novo Nordisk A/S - share repurchase programme
globenewswire.com
NVO
Parker Waichman LLP Files Lawsuit on behalf of Florida Resident Alleging Development of Irreversible Eye Condition, NAION, after taking Ozempic and Mounjaro
prnewswire.com
NVO
LLY
Felix Offers Ozempic at Generic-Level Pricing as Lower-Cost GLP-1 Demand Remains Elevated Across Canada
globenewswire.com
NVO
Gala Health: High-Quality Compounded GLP-1 Weight Loss & Hormone Therapy HRT Support
globenewswire.com
NVO
LLY
The 'Hidden' Side Effect of Weight-Loss Drugs That Could Be Affecting Your Mouth, warns Oralieve
prnewswire.com
NVO
LLY
GLP-1 Receptor Agonist Market Projected to Reach USD 307 Billion by 2035 Driven by Expanding Metabolic Disease Burden – SNS Insider
globenewswire.com
LLY
NVO
Novo Nordisk A/S - share repurchase programme
globenewswire.com
NVO